International Journal of Epidemiology, Vol 26, 14-23, Copyright © 1997 by International Epidemiological Association
A Charloux, E Quoix, N Wolkove, D Small, G Pauli and H Kreisman
Lung adenocarcinoma is the most common cell type in females (smokers or
non-smokers) and in non-smoking males. Its incidence has been increasing in
younger cohorts of males and females until very recent years. Changes in
classification and in pathological techniques account for some of this
increase. In females and non-smoker males, the increase could be partly due
to a detection bias in former studies. Nevertheless, successive cohorts
over time seem more likely to develop adenocarcinoma and less likely to
develop squamous cell carcinoma. These differences between birth cohorts
suggest that the increasing incidence of adenocarcinoma is not only due to
changes in pathological diagnosis. Geographical differences are also
observed: in Europe, the squamous cell type still predominates and an
increase in incidence of adenocarcinoma has only been reported in the
Netherlands. In Asia, in the 1960s and 1970s, the proportion of
adenocarcinoma was higher than in North America or Europe and seems to be
increasing. To what extent these differences are due to differences. In
establishing diagnosis remains unknown. Despite these biases in temporal
and geographical trends detailed in this review, there has probably been a
true increase in incidence of adenocarcinoma. An explanation for this
should be sought in studies on detailed smoking history and passive smoking
exposure, occupational exposure, diet and cooking, pollution and other
environmental factors.
ARTICLES
The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma
Pulmonary Division, Jewish General Hospital, McGill University, Montreal, (Quebec), Canada.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Hosseini, P. A. Naghan, S. Karimi, S. SeyedAlinaghi, M. Bahadori, K. Khodadad, F. Mohammadi, K. Keynama, and M. R. Masjedi Environmental risk factors for lung cancer in Iran: a case-control study Int. J. Epidemiol., August 1, 2009; 38(4): 989 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-R. Wang, Y.-L. Chiu, H. Qiu, J. S. K. Au, and I. T.-S. Yu The roles of smoking and cooking emissions in lung cancer risk among Chinese women in Hong Kong Ann. Onc., April 1, 2009; 20(4): 746 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. THOM, O. SCHULT-KRONEFELD, I. BURKHOLDER, G. SCHUCH, B. ANDRITZKY, H. KASTENDIECK, L. EDLER, C. WAGENER, C. BOKEMEYER, U. SCHUMACHER, et al. Expression of CEACAM-1 in Pulmonary Adenocarcinomas and their Metastases Anticancer Res, January 1, 2009; 29(1): 249 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D.F. Licchesi, W. H. Westra, C. M. Hooker, and J. G. Herman Promoter Hypermethylation of Hallmark Cancer Genes in Atypical Adenomatous Hyperplasia of the Lung Clin. Cancer Res., May 1, 2008; 14(9): 2570 - 2578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Pereira-Faca, R. Kuick, E. Puravs, Q. Zhang, A. L. Krasnoselsky, D. Phanstiel, J. Qiu, D. E. Misek, R. Hinderer, M. Tammemagi, et al. Identification of 14-3-3{theta} as an Antigen that Induces a Humoral Response in Lung Cancer Cancer Res., December 15, 2007; 67(24): 12000 - 12006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Alberg, J. G. Ford, and J. M. Samet Epidemiology of Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 29S - 55S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Chen, W. F. Bina, and P. Cole Declining Incidence Rate of Lung Adenocarcinoma in the United States Chest, April 1, 2007; 131(4): 1000 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Raimondi, V Paracchini, H Autrup, J. Barros-Dios, S Benhamou, P Boffetta, M. Cote, I. Dialyna, V Dolzan, R Filiberti, et al. Meta- and Pooled Analysis of GSTT1 and Lung Cancer: A HuGE-GSEC Review Am. J. Epidemiol., December 1, 2006; 164(11): 1027 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Cadranel, D Garfield, A Lavole, M Wislez, B Milleron, and C Mayaud Lung cancer in HIV infected patients: facts, questions and challenges. Thorax, November 1, 2006; 61(11): 1000 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Govindan, N. Page, D. Morgensztern, W. Read, R. Tierney, A. Vlahiotis, E. L. Spitznagel, and J. Piccirillo Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results Database J. Clin. Oncol., October 1, 2006; 24(28): 4539 - 4544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Gray The consequences of the unregulated cigarette. Tob. Control, October 1, 2006; 15(5): 405 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Okamoto, R. Maruyama, R. Suemitsu, Y. Aoki, H. Wataya, M. Kojo, and Y. Ichinose Prognostic value of the histological subtype in completely resected non-small cell lung cancer Interactive CardioVascular and Thoracic Surgery, August 1, 2006; 5(4): 362 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chao, Z.-F. Zhang, J. Berthiller, P. Boffetta, and M. Hashibe NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Pro187Ser Polymorphism and the Risk of Lung, Bladder, and Colorectal Cancers: a Meta-analysis. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 979 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Guo, K. Higashi, Y. Ueda, M. Oguchi, T. Takegami, H. Toga, T. Sakuma, H. Yokota, S. Katsuda, H. Tonami, et al. Microvessel Density: Correlation with 18F-FDG Uptake and Prognostic Impact in Lung Adenocarcinomas J. Nucl. Med., March 1, 2006; 47(3): 419 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. H. Yun, M. K. Lim, K. W. Jung, J.-M. Bae, S. M. Park, S. A. Shin, J. S. Lee, and J.-G. Park Relative and Absolute Risks of Cigarette Smoking on Major Histologic Types of Lung Cancer in Korean Men Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2125 - 2130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Alberg, M. V. Brock, and J. M. Samet Epidemiology of Lung Cancer: Looking to the Future J. Clin. Oncol., May 10, 2005; 23(14): 3175 - 3185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Brooks, J. H.M. Austin, R. T. Heelan, M. S. Ginsberg, V. Shin, S. H. Olson, J. E. Muscat, and S. D. Stellman Influence of Type of Cigarette on Peripheral versus Central Lung Cancer Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 576 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Butkiewicz, O. Popanda, A. Risch, L. Edler, H. Dienemann, V. Schulz, K. Kayser, P. Drings, H. Bartsch, and P. Schmezer Association between the Risk for Lung Adenocarcinoma and a (-4) G-to-A Polymorphism in the XPA Gene Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2242 - 2246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-K. Toh, E.-H. Wong, W.-T. Lim, S.-S. Leong, K.-W. Fong, J. Wee, and E.-H. Tan The Impact of Smoking Status on the Behavior and Survival Outcome of Patients With Advanced Non-small Cell Lung Cancer: A Retrospective Analysis Chest, December 1, 2004; 126(6): 1750 - 1756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Yanagitani, T. Kohno, J.-G. Kim, H. Kunitoh, T. Tamura, Y. Takei, S. Tsuchiya, R. Saito, and J. Yokota Identification of D19S246 as a Novel Lung Adenocarcinoma Susceptibility Locus by Genome Survey with 10-cM Resolution Microsatellite Markers Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 366 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sioris, R. Jarvenpaa, P. Kuukasjarvi, H. Helin, S. Saarelainen, and M. Tarkka Comparison of computed tomography and systematic lymph node dissection in determining TNM and stage in non-small cell lung cancer Eur. J. Cardiothorac. Surg., March 1, 2003; 23(3): 403 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Cave-Riant, B. Cuillerier, M. Beau-Faller, N. Martinet, F. Alla, C. Bronner, A. Schneider, P. Oudet, and M. P. Gaub Association of Genetic Defects in Primary Resected Lung Adenocarcinoma Revealed by Targeted Allelic Imbalance Analysis Am. J. Respir. Cell Mol. Biol., October 1, 2002; 27(4): 495 - 502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sunaga, T. Kohno, N. Yanagitani, H. Sugimura, H. Kunitoh, T. Tamura, Y. Takei, S. Tsuchiya, R. Saito, and J. Yokota Contribution of the NQO1 and GSTT1 Polymorphisms to Lung Adenocarcinoma Susceptibility Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 730 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Yanagitani, T. Kohno, N. Sunaga, H. Kunitoh, T. Tamura, S. Tsuchiya, R. Saito, and J. Yokota Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12.1 Carcinogenesis, July 1, 2002; 23(7): 1177 - 1183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Brambilla, W.D. Travis, T.V. Colby, B. Corrin, and Y. Shimosato The new World Health Organization classification of lung tumours Eur. Respir. J., December 1, 2001; 18(6): 1059 - 1068. [Abstract] [Full Text] [PDF]
|
|